KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
May 18, 2020 $4.20 $4.32 $4.13 $4.18 271 716
May 15, 2020 $4.29 $4.34 $4.06 $4.10 264 962
May 14, 2020 $4.25 $4.50 $4.14 $4.27 257 274
May 13, 2020 $4.85 $4.85 $4.07 $4.49 404 983
May 12, 2020 $4.96 $4.96 $4.47 $4.54 312 746
May 11, 2020 $4.05 $4.72 $4.05 $4.66 507 619
May 08, 2020 $4.26 $4.34 $3.93 $4.08 242 314
May 07, 2020 $4.03 $4.25 $3.96 $4.23 226 878
May 06, 2020 $4.02 $4.17 $3.94 $4.03 82 355
May 05, 2020 $4.02 $4.10 $3.98 $4.02 137 477
May 04, 2020 $3.93 $4.11 $3.87 $3.94 152 289
May 01, 2020 $3.66 $3.99 $3.56 $3.95 278 893
Apr 30, 2020 $3.94 $3.94 $3.56 $3.73 286 592
Apr 29, 2020 $4.00 $4.20 $3.83 $3.86 261 310
Apr 28, 2020 $4.09 $4.09 $3.83 $3.91 130 331
Apr 27, 2020 $3.98 $4.14 $3.92 $3.97 200 238
Apr 24, 2020 $3.90 $3.97 $3.85 $3.89 101 598
Apr 23, 2020 $4.03 $4.17 $3.85 $3.87 179 934
Apr 22, 2020 $4.03 $4.04 $3.92 $3.95 119 044
Apr 21, 2020 $3.94 $4.07 $3.85 $3.91 99 772
Apr 20, 2020 $4.04 $4.21 $3.98 $4.00 97 700
Apr 17, 2020 $4.04 $4.22 $3.98 $4.05 97 702
Apr 16, 2020 $4.20 $4.28 $3.88 $3.92 173 031
Apr 15, 2020 $3.74 $4.22 $3.63 $4.10 214 276
Apr 14, 2020 $3.83 $4.01 $3.80 $3.85 145 757
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT